Business Context and Reporting Period
This Form 8-K was filed by Kura Oncology, Inc. on March 12, 2015, reporting events occurring on March 6, 2015. The filing details the completion of a merger transaction among Zeta Acquisition Corp. III, Kura Operations, Inc., and Kura Oncology, Inc. Stockholders holding 80% of issued and outstanding shares executed a written consent in lieu of a meeting to approve the transaction and related corporate actions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and structural changes rather than financial performance.
Material Changes
The primary material change is the consummation of the Merger. Following the written consent, the company relinquished the name "Zeta Acquisition Corp. III" and assumed the name "Kura Oncology, Inc." Additionally, a newly organized wholly-owned subsidiary named "Kura Oncology, Inc." merged with and into the parent company, leaving the parent as the surviving corporation.
Guidance, Outlook, and Management Commentary
The filing does not contain financial guidance, outlook, or management commentary regarding future operations. However, it outlines several approved corporate actions effective 20 days after the mailing of a definitive Schedule 14C information statement:
- Assumption and amendment of the 2014 Equity Incentive Plan.
- Adoption of the 2015 Employee Stock Purchase Plan.
- Amendment and restatement of the certificate of incorporation.
- Amendment and restatement of the bylaws.
- Execution of indemnification agreements for directors and officers.
Investor Verification Checklist
- Verify the definitive Schedule 14C information statement for the effective dates of the equity plans and charter amendments.
- Confirm the final corporate name change from Zeta Acquisition Corp. III to Kura Oncology, Inc. in subsequent filings.
- Review the terms of the assumed 2014 Equity Incentive Plan and the new 2015 Employee Stock Purchase Plan.
- Check for any subsequent filings regarding the merger of the subsidiary to ensure the surviving entity status is correctly recorded.